Micro-RNA Implications in Type-1 Diabetes Mellitus: A Review of Literature
Abstract
:1. Introduction
2. MiRNAs
2.1. History
2.2. MiRNA Genomic Distribution
2.3. Biogenesis Pathway and Maturation of miRNAs
2.4. Mechanism of Action
2.5. MiRNAs’ Role as Biomarkers
2.6. MiRNA Implications in Diseases
3. Role of miRNAs in T1DM
4. Diagnostic Role in T1DM and Future Perspectives
5. Bioinformatics Analysis
6. MiRNAs and Therapeutic Prospects
7. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Mayer-Davis, E.J.; Kahkoska, A.R.; Jefferies, C.; Dabelea, D.; Balde, N.; Gong, C.X.; Aschner, P.; Craig, M.E. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatric Diabetes 2018, 19, 7–19. [Google Scholar] [CrossRef] [PubMed]
- Ozougwu, O. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J. Physiol. Pathophysiol. 2013, 4, 46–57. [Google Scholar] [CrossRef] [Green Version]
- Ounissi-Benkalha, H.; Polychronakos, C. The molecular genetics of type 1 diabetes: New genes and emerging mechanisms. Trends Mol. Med. 2008, 14, 268–275. [Google Scholar] [CrossRef] [PubMed]
- Atkinson, M.A. The pathogenesis and natural history of type 1 diabetes. Cold Spring Harb. Perspect. Med. 2012, 2, a007641. [Google Scholar] [CrossRef] [PubMed]
- Csorba, T.R.; Lyon, A.W.; Hollenberg, M.D. Autoimmunity and the pathogenesis of type 1 diabetes. Crit. Rev. Clin. Lab. Sci. 2010, 47, 51–71. [Google Scholar] [CrossRef] [PubMed]
- Gonzalez, C.D.; Lee, M.-S.; Marchetti, P.; Pietropaolo, M.; Towns, R.; Vaccaro, M.I.; Watada, H.; Wiley, J.W. The emerging role of autophagy in the pathophysiology of diabetes mellitus. Autophagy 2011, 7, 2–11. [Google Scholar] [CrossRef] [PubMed]
- Aribi, M. Autoimmunity and Immunotherapy of Type 1 Diabetes. In Type 1 Diabetes—Pathogenesis, Genetics and Immunotherapy; David, W., Ed.; IntechOpen: London, UK, 2011; ISBN 978-953-307-362-0. [Google Scholar]
- Jerram, S.T.; Dang, M.N.; Leslie, R.D. The Role of Epigenetics in Type 1 Diabetes. Curr. Diabetes Rep. 2017, 17, 89. [Google Scholar] [CrossRef]
- MacFarlane, A.J.; Strom, A.; Scott, F.W. Epigenetics: Deciphering how environmental factors may modify autoimmune type 1 diabetes. Mamm. Genome 2009, 20, 624–632. [Google Scholar] [CrossRef] [PubMed]
- Miao, F.; Chen, Z.; Genuth, S.; Paterson, A.; Zhang, L.; Wu, X.; Li, S.M.; Cleary, P.; Riggs, A.; Harlan, D.M.; et al. Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes. Diabetes 2014, 63, 1748–1762. [Google Scholar] [CrossRef] [Green Version]
- Miao, C.; Chang, J.; Zhang, G.; Fang, Y. MicroRNAs in type 1 diabetes: New research progress and potential directions. Biochem. Cell Biol. 2018, 96, 498–506. [Google Scholar] [CrossRef] [PubMed]
- Vasudevan, S.; Tong, Y.; Steitz, J.A. Switching from repression to activation: MicroRNAs can up-regulate translation. Science 2007, 318, 1931–1934. [Google Scholar] [CrossRef] [Green Version]
- Filipowicz, W.; Bhattacharyya, S.N.; Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat. Rev. Genet. 2008, 9, 102–114. [Google Scholar] [CrossRef]
- Feinbaum, R.; Ambros, V.; Lee, R. The C. elegans Heterochronic Gene lin-4 Encodes Small RNAs with Antisense Complementarity to lin-14. Cell 2004, 116, 843–854. [Google Scholar]
- Bartel, D.P. MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell 2004, 116, 281–297. [Google Scholar] [CrossRef] [Green Version]
- Almeida, M.I.; Reis, R.M.; Calin, G.A. MicroRNA history: Discovery, recent applications, and next frontiers. Mutat. Res. Fundam. Mol. Mech. Mutagen. 2011, 717, 1–8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Reinhart, B.J.; Slack, F.J.; Basson, M.; Pasquienelll, A.E.; Bettlnger, J.C.; Rougvle, A.E.; Horvitz, H.R.; Ruvkun, G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403, 901–906. [Google Scholar] [CrossRef] [PubMed]
- Pasquinelli, A.E.; Reinhart, B.J.; Slack, F.; Martindale, M.Q.; Kuroda, M.I.; Maller, B.; Hayward, D.C.; Ball, E.E.; Degnan, B.; Müller, P.; et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000, 408, 86–89. [Google Scholar] [CrossRef]
- Lagos-Quintana, M.; Rauhut, R.; Lendeckel, W.; Tuschl, T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294, 853–858. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kim, V.N.; Nam, J.W. Genomics of microRNA. Trends Genet. 2006, 22, 165–173. [Google Scholar] [CrossRef] [PubMed]
- Rodriguez, A.; Griffiths-Jones, S.; Ashurst, J.L.; Bradley, A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004, 14, 1902–1910. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- John, B.; Enright, A.J.; Aravin, A.; Tuschl, T.; Sander, C.; Marks, D.S. Human microRNA targets. PLoS Biol. 2004, 2, e363. [Google Scholar] [CrossRef] [Green Version]
- O’Brien, J.; Hayder, H.; Zayed, Y.; Peng, C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front. Endocrinol. 2018, 9, 402. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wahid, F.; Shehzad, A.; Khan, T.; Kim, Y.Y. MicroRNAs: Synthesis, mechanism, function, and recent clinical trials. Biochim. Biophys. Acta Mol. Cell Res. 2010, 1803, 1231–1243. [Google Scholar] [CrossRef] [Green Version]
- Wang, J.; Wu, Z.; Li, D.; Li, N.; Dindot, S.V.; Satterfield, M.C.; Bazer, F.W.; Wu, G. Nutrition, epigenetics, and metabolic syndrome. Antioxid. Redox Signal. 2012, 17, 282–301. [Google Scholar] [CrossRef]
- Bushati, N.; Cohen, S.M. microRNA Functions. Annu. Rev. Cell Dev. Biol. 2007, 23, 175–205. [Google Scholar] [CrossRef] [PubMed]
- Fabian, M.R.; Sonenberg, N.; Filipowicz, W. Regulation of mRNA Translation and Stability by microRNAs. Annu. Rev. Biochem. 2010, 79, 351–379. [Google Scholar] [CrossRef] [Green Version]
- Lou, S.; Sun, T.; Li, H.; Hu, Z. Mechanisms of microRNA-mediated gene regulation in unicellular model alga Chlamydomonas reinhardtii. Biotechnol. Biofuels 2018, 11, 244. [Google Scholar] [CrossRef]
- Fabbri, M. MicroRNAs and mirceptors: A new mechanism of action for intercellular communication. Philos. Trans. R. Soc. B Biol. Sci. 2018, 373, 20160486. [Google Scholar] [CrossRef] [PubMed]
- De Planell-Saguer, M.; Rodicio, M.C. Analytical aspects of microRNA in diagnostics: A review. Anal. Chim. Acta 2011, 699, 134–152. [Google Scholar] [CrossRef]
- Wittmann, J.; Jäck, H.M. Serum microRNAs as powerful cancer biomarkers. Biochim. Biophys. Acta Rev. Cancer 2010, 1806, 200–207. [Google Scholar] [CrossRef] [PubMed]
- Rosenfeld, N.; Aharonov, R.; Meiri, E.; Rosenwald, S.; Spector, Y.; Zepeniuk, M.; Benjamin, H.; Shabes, N.; Tabak, S.; Levy, A.; et al. MicroRNAs accurately identify cancer tissue origin. Nat. Biotechnol. 2008, 26, 462–469. [Google Scholar] [CrossRef]
- Edwards, J.K.; Pasqualini, R.; Arap, W.; Calin, G.A. MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases. J. Cardiovasc. Transl. Res. 2010, 3, 271–279. [Google Scholar] [CrossRef] [PubMed]
- Garzon, R.; Calin, G.A.; Croce, C.M. MicroRNAs in Cancer. Annu. Rev. Med. 2009, 60, 167–179. [Google Scholar] [CrossRef] [Green Version]
- Wang, H.; Peng, R.; Wang, J.; Qin, Z.; Xue, L. Circulating microRNAs as potential cancer biomarkers: The advantage and disadvantage. Clin. Epigenetics 2018, 10, 59. [Google Scholar] [CrossRef] [Green Version]
- Wu, W.K.K.; Lee, C.W.; Cho, C.H.; Fan, D.; Wu, K.; Yu, J.; Sung, J.J.Y. MicroRNA dysregulation in gastric cancer: A new player enters the game. Oncogene 2010, 29, 5761–5771. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tribolet, L.; Kerr, E.; Cowled, C.; Bean, A.G.D.; Stewart, C.R.; Dearnley, M.; Farr, R.J. MicroRNA Biomarkers for Infectious Diseases: From Basic Research to Biosensing. Front. Microbiol. 2020, 11, 1197. [Google Scholar] [CrossRef] [PubMed]
- Li, Y.; Kowdley, K.V. MicroRNAs in Common Human Diseases. Genom. Proteom. Bioinform. 2012, 10, 246–253. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Huang, J.; Borchert, G.M.; Dou, D.; Huan, L.; Lan, W.; Tan, M.; Wu, B. Bioinformatics in MicroRNA Research; Humana Press: New York, NY, USA, 2017. [Google Scholar]
- Roser, A.E.; Gomes, L.C.; Schünemann, J.; Maass, F.; Lingor, P. Circulating miRNAs as diagnostic biomarkers for Parkinson’s disease. Front. Neurosci. 2018, 12, 625. [Google Scholar] [CrossRef]
- Mandal, P.; De, D.; Im, D.U.; Um, S.H.; Kim, K.K. Exosome-mediated differentiation of mouse embryonic fibroblasts and exocrine cells into β-like cells and the identification of key mirnas for differentiation. Biomedicines 2020, 8, 485. [Google Scholar] [CrossRef]
- Sun, X.; Ji, G.; Li, P.; Li, W.; Li, J.; Zhu, L. miR-344-5p Modulates Cholesterol-Induced β-Cell Apoptosis and Dysfunction through Regulating Caveolin-1 Expression. Front. Endocrinol. 2021, 12, 898. [Google Scholar] [CrossRef] [PubMed]
- Wong, W.K.M.; Sørensen, A.E.; Joglekar, M.V.; Hardikar, A.A.; Dalgaard, L.T. Non-coding RNA in pancreas and β-cell development. Non-Coding RNA 2018, 4, 41. [Google Scholar] [CrossRef] [Green Version]
- Garcia-Contreras, M.; Shah, S.H.; Tamayo, A.; Robbins, P.D.; Golberg, R.B.; Mendez, A.J.; Ricordi, C. Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes. Sci. Rep. 2017, 7, 5998. [Google Scholar] [CrossRef]
- Samandari, N.; Mirza, A.H.; Kaur, S.; Hougaard, P.; Nielsen, L.B.; Fredheim, S.; Mortensen, H.B.; Pociot, F. Influence of disease duration on circulating levels of miRNAs in children and adolescents with new onset type 1 diabetes. Non-Coding RNA 2018, 4, 35. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lakhter, A.J.; Pratt, R.E.; Moore, R.E.; Doucette, K.K.; Maier, B.F.; DiMeglio, L.A.; Sims, E.K. Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes. Diabetologia 2018, 61, 1124–1134. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Grieco, G.E.; Cataldo, D.; Ceccarelli, E.; Nigi, L.; Catalano, G.; Brusco, N.; Mancarella, F.; Ventriglia, G.; Fondelli, C.; Guarino, E.; et al. Serum levels of miR-148a and miR-21-5p are increased in type 1 diabetic patients and correlated with markers of bone strength and metabolism. Non-Coding RNA 2018, 4, 37. [Google Scholar] [CrossRef] [Green Version]
- Roggli, E.; Gattesco, S.; Caille, D.; Briet, C.; Boitard, C.; Meda, P.; Regazzi, R. Changes in microRNA expression contribute to pancreatic β-cell dysfunction in prediabetic NOD mice. Diabetes 2012, 61, 1742–1751. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Samandari, N.; Mirza, A.H.; Nielsen, L.B.; Kaur, S.; Hougaard, P.; Fredheim, S.; Mortensen, H.B.; Pociot, F. Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitus. Diabetologia 2017, 60, 354–363. [Google Scholar] [CrossRef] [Green Version]
- Nabih, E.S.; Andrawes, N.G. The Association Between Circulating Levels of miRNA-181a and Pancreatic Beta Cells Dysfunction via SMAD7 in Type 1 Diabetic Children and Adolescents. J. Clin. Lab. Anal. 2016, 30, 727–731. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gao, Y.; Zhang, R.; Dai, S.; Zhang, X.; Li, X.; Bai, C. Role of TGF-β/Smad Pathway in the Transcription of Pancreas-Specific Genes During Beta Cell Differentiation. Front. Cell Dev. Biol. 2019, 7, 351. [Google Scholar] [CrossRef] [PubMed]
- Joglekar, M.V.; Parekh, V.S.; Mehta, S.; Bhonde, R.R.; Hardikar, A.A. MicroRNA profiling of developing and regenerating pancreas reveal post-transcriptional regulation of neurogenin3. Dev. Biol. 2007, 311, 603–612. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nielsen, L.B.; Wang, C.; Sørensen, K.; Bang-Berthelsen, C.H.; Hansen, L.; Andersen, M.L.M.; Hougaard, P.; Juul, A.; Zhang, C.Y.; Pociot, F.; et al. The role of MicroRNAs in the pathogenesis of diabetic nephropathy. Diabetes 2011, 20, 110509. [Google Scholar] [CrossRef]
- Correa-Medina, M.; Bravo-Egana, V.; Rosero, S.; Ricordi, C.; Edlund, H.; Diez, J.; Pastori, R.L. MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas. Gene Expr. Patterns 2009, 9, 193–199. [Google Scholar] [CrossRef] [PubMed]
- Berry, G.J.; Budgeon, L.R.; Cooper, T.K.; Christensen, N.D.; Waldner, H. The type 1 diabetes resistance locus B10 Idd9.3 mediates impaired B-cell lymphopoiesis and implicates microRNA-34a in diabetes protection. Eur. J. Immunol. 2014, 44, 1716–1727. [Google Scholar] [CrossRef]
- Zheng, Y.; Wang, Z.; Zhou, Z. MiRNAs: Novel regulators of autoimmunity-mediated pancreatic β-cell destruction in type 1 diabetes. Cell. Mol. Immunol. 2017, 14, 488–496. [Google Scholar] [CrossRef] [Green Version]
- Scherm, M.G.; Daniel, C. miRNA-Mediated Immune Regulation in Islet Autoimmunity and Type 1 Diabetes. Front. Endocrinol. 2020, 11, 606322. [Google Scholar] [CrossRef]
- Abuhatzira, L.; Xu, H.; Tahhan, G.; Boulougoura, A.; Schäffer, A.A.; Notkins, A.L. Multiple microRNAs within the 14q32 cluster target the mRNAs of major type 1 diabetes autoantigens IA-2, IA-2b, and GAD65. FASEB J. 2015, 29, 4374–4383. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Poy, M.N.; Eliasson, L.; Krutzfeldt, J.; Kuwajima, S.; Tuschl, T.; Rajewsky, N.; Rorsman, P.; Stoffel, M. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432, 226–230. [Google Scholar] [CrossRef] [PubMed]
- Matarese, A.; Gambardella, J.; Lombardi, A.; Wang, X.; Santulli, G. miR-7 Regulates GLP-1-Mediated Insulin Release by Targeting β-Arrestin 1. Cells 2020, 9, 1621. [Google Scholar] [CrossRef]
- Assmann, T.S.; Recamonde-Mendoza, M.; de Souza, B.M.; Bauer, A.C.; Crispim, D. MicroRNAs and diabetic kidney disease: Systematic review and bioinformatic analysis. Mol. Cell. Endocrinol. 2018, 477, 90–102. [Google Scholar] [CrossRef] [PubMed]
- Assmann, T.S.; Recamonde-Mendoza, M.; Costa, A.R.; Puñales, M.; Tschiedel, B.; Canani, L.H.; Bauer, A.C.; Crispim, D. Circulating miRNAs in diabetic kidney disease: Case–control study and in silico analyses. Acta Diabetol. 2019, 56, 55–65. [Google Scholar] [CrossRef]
- Simpson, K.; Wonnacott, A.; Fraser, D.J.; Bowen, T. MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy. Curr. Diabetes Rep. 2016, 16, 35. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kantharidis, P.; Wang, B.; Carew, R.M.; Lan, H.Y. Diabetes complications: The microRNA perspective. Diabetes 2011, 60, 1832–1837. [Google Scholar] [CrossRef] [Green Version]
- Mcclelland, A.D.; Kantharidis, P. MicroRNA in the development of diabetic complications. Clin. Sci. 2014, 126, 95–110. [Google Scholar] [CrossRef] [PubMed]
- Pordzik, J.; Eyileten-Postuła, C.; Jakubik, D.; Czajka, P.; Nowak, A.; De Rosa, S.; Gasecka, A.; Cieślicka-Kapłon, A.; Sulikowski, P.; Filipiak, K.J.; et al. Mir-126 is an independent predictor of long-term all-cause mortality in patients with type 2 diabetes mellitus. J. Clin. Med. 2021, 10, 2371. [Google Scholar] [CrossRef]
- Jankauskas, S.S.; Gambardella, J.; Sardu, C.; Lombardi, A.; Santulli, G. Functional role of miR-155 in the pathogenesis of diabetes mellitus and its complications. Non-Coding RNA 2021, 7, 39. [Google Scholar] [CrossRef] [PubMed]
- Nielsen, L.B.; Wang, C.; Sørensen, K.; Bang-Berthelsen, C.H.; Hansen, L.; Andersen, M.L.M.; Hougaard, P.; Juul, A.; Zhang, C.Y.; Pociot, F.; et al. Circulating levels of MicroRNA from children with newly diagnosed type 1 diabetes and healthy controls: Evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Exp. Diabetes Res. 2012, 2012, 896362. [Google Scholar] [CrossRef] [Green Version]
- Osipova, J.; Fischer, D.C.; Dangwal, S.; Volkmann, I.; Widera, C.; Schwarz, K.; Lorenzen, J.M.; Schreiver, C.; Jacoby, U.; Heimhalt, M.; et al. Diabetes-associated MicroRNAs in pediatric patients with type 1 diabetes mellitus: A cross-sectional cohort study. J. Clin. Endocrinol. Metab. 2014, 99, E1661–E1665. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Åkerman, L.; Casas, R.; Ludvigsson, J.; Tavira, B.; Skoglund, C. Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes. PLoS ONE 2018, 13, e0191067. [Google Scholar] [CrossRef]
- Erener, S.; Marwaha, A.; Tan, R.; Panagiotopoulos, C.; Kieffer, T.J. Profiling of circulating microRNAs in children with recent onset of type 1 diabetes. JCI Insight 2017, 2, e89656. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Santos, A.S.; Cunha Neto, E.; Fukui, R.T.; Ferreira, L.R.P.; Silva, M.E.R. Increased Expression of Circulating microRNA 101-3p in Type 1 Diabetes Patients: New Insights Into miRNA-Regulated Pathophysiological Pathways for Type 1 Diabetes. Front. Immunol. 2019, 10, 1637. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Marchand, L.; Jalabert, A.; Meugnier, E.; Van Den Hende, K.; Fabien, N.; Nicolino, M.; Madec, A.M.; Thivolet, C.; Rome, S. MiRNA-375 a Sensor of Glucotoxicity Is Altered in the Serum of Children with Newly Diagnosed Type 1 Diabetes. J. Diabetes Res. 2016, 2016, 1869082. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chi, T.; Lin, J.; Wang, M.; Zhao, Y.; Liao, Z.; Wei, P. Non-Coding RNA as Biomarkers for Type 2 Diabetes Development and Clinical Management. Front. Endocrinol. 2021, 12, 32. [Google Scholar] [CrossRef] [PubMed]
- Zhu, Z.; Zhang, Y.; Bai, R.; Yang, R.; Shan, Z.; Ma, C.; Yang, J.; Sun, D. Association of Genetic Polymorphisms in MicroRNAs With Type 2 Diabetes Mellitus in a Chinese Population. Front. Endocrinol. 2021, 11, 587561. [Google Scholar] [CrossRef] [PubMed]
- Snowhite, I.V.; Allende, G.; Sosenko, J.; Pastori, R.L.; Messinger Cayetano, S.; Pugliese, A. Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes. Diabetologia 2017, 60, 1409–1422. [Google Scholar] [CrossRef] [PubMed]
- Liu, Y.; Ma, M.; Yu, J.; Ping, F.; Zhang, H.; Li, W.; Xu, L.; Li, Y. Decreased Serum microRNA-21, microRNA-25, microRNA-146a, and microRNA-181a in Autoimmune Diabetes: Potential Biomarkers for Diagnosis and Possible Involvement in Pathogenesis. Int. J. Endocrinol. 2019, 2019, 8406438. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sidorkiewicz, I.; Niemira, M.; Maliszewska, K.; Erol, A.; Bielska, A.; Szalkowska, A.; Adamska-Patruno, E.; Szczerbinski, L.; Gorska, M.; Kretowski, A. Circulating mirnas as a predictive biomarker of the progression from prediabetes to diabetes: Outcomes of a 5-year prospective observational study. J. Clin. Med. 2020, 9, 2184. [Google Scholar] [CrossRef] [PubMed]
- Al-Muhtaresh, H.A.; Al-Kafaji, G. Evaluation of two-diabetes related microRNAs suitability as earlier blood biomarkers for detecting prediabetes and type 2 diabetes mellitus. J. Clin. Med. 2018, 7, 12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kaur, S.; Mirza, A.H.; Pociot, F. Cell type-selective expression of circular RNAs in human pancreatic islets. Non-Coding RNA 2018, 4, 38. [Google Scholar] [CrossRef] [Green Version]
- Brown, J.; Sanseau, P. A computational view of microRNAs and their targets. Drug Discov. Today 2005, 10, 595–601. [Google Scholar] [CrossRef]
- Griffiths-Jones, S. miRBase: The microRNA sequence database. Methods Mol. Biol. 2006, 342, 129–138. [Google Scholar] [CrossRef]
- Bentwich, I. Prediction and validation of microRNAs and their targets. FEBS Lett. 2005, 579, 5904–5910. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hanna, J.; Hossain, G.S.; Kocerha, J. The potential for microRNA therapeutics and clinical research. Front. Genet. 2019, 10, 478. [Google Scholar] [CrossRef] [Green Version]
- Assmann, T.S.; Recamonde-Mendoza, M.; Puñales, M.; Tschiedel, B.; Canani, L.H.; Crispim, D. MicroRNA expression profile in plasma from type 1 diabetic patients: Case-control study and bioinformatic analysis. Diabetes Res. Clin. Pract. 2018, 141, 35–46. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Huang, W. MicroRNAs: Biomarkers, Diagnostics, and Therapeutics. Methods Mol. Biol. 2017, 1617, 57–67. [Google Scholar] [CrossRef]
- Kolfschoten, I.G.M.; Roggli, E.; Nesca, V.; Regazzi, R. Role and therapeutic potential of microRNAs in diabetes. Diabetes Obes. Metab. 2009, 11, 118–129. [Google Scholar] [CrossRef] [PubMed]
- Mao, Y.; Mohan, R.; Zhang, S.; Tang, X. MicroRNAs as pharmacological targets in diabetes. Pharmacol. Res. 2013, 75, 37–47. [Google Scholar] [CrossRef] [Green Version]
- Kota, J.; Chivukula, R.; O’Donnell, K.; Wentzel, E.; Montgomery, C.; Hwang, H.; Chang, T.; Vivekanandan, P.; Torbenson, M.; Clark, K.; et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 137, 1005–1017. [Google Scholar] [CrossRef] [Green Version]
- Ahmed, F.W.; Bakhashab, S.; Bastaman, I.T.; Crossland, R.E.; Glanville, M.; Weaver, J.U. Anti-angiogenic miR-222, miR-195, and miR-21a plasma levels in T1DM are improved by metformin therapy, thus elucidating its cardioprotective effect: The MERIT study. Int. J. Mol. Sci. 2018, 19, 3242. [Google Scholar] [CrossRef] [Green Version]
- Ghai, V.; Kim, T.K.; Etheridge, A.; Nielsen, T.; Hansen, T.; Pedersen, O.; Galas, D.; Wang, K. Extracellular vesicle encapsulated MicroRNAs in patients with type 2 diabetes are affected by metformin treatment. J. Clin. Med. 2019, 8, 617. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chang, W.; Wang, J. Exosomes and Their Noncoding RNA Cargo Are Emerging as New Modulators for Diabetes Mellitus. Cells 2019, 8, 853. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nandi, S.S.; Shahshahan, H.R.; Shang, Q.; Kutty, S.; Boska, M.; Mishra, P.K. MiR-133a mimic alleviates T1DM-induced systolic dysfunction in akita: An MRI-based study. Front. Physiol. 2018, 9, 1275. [Google Scholar] [CrossRef] [PubMed]
- Wan, S.; Zhang, J.; Chen, X.; Lang, J.; Li, L.; Chen, F.; Tian, L.; Meng, Y.; Yu, X. MicroRNA-17-92 Regulates Beta-Cell Restoration After Streptozotocin Treatment. Front. Endocrinol. 2020, 11, 9. [Google Scholar] [CrossRef] [Green Version]
- Bai, C.; Ren, Q.; Liu, H.; Li, X. miR-212/132-enriched extracellular vesicles promote differentiation of induced pluripotent stem cells into pancreatic beta cells. Front Cell Dev. Biol. 2021, 9, 673231. [Google Scholar] [CrossRef] [PubMed]
- Chen, H.; Lan, H.Y.; Roukos, D.H.; Cho, W.C. Application of microRNAs in diabetes mellitus. J. Endocrinol. 2014, 222, R1–R10. [Google Scholar] [CrossRef]
- Capuani, B.; Pacifici, F.; Della-Morte, D.; Lauro, D. Glucagon Like Peptide 1 and MicroRNA in Metabolic Diseases: Focusing on GLP1 Action on miRNAs. Front. Endocrinol. 2018, 9, 719. [Google Scholar] [CrossRef] [PubMed]
- Coulson, D.J.; Bakhashab, S.; Latief, J.S.; Weaver, J.U. MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus). J. Transl. Med. 2021, 19, 140. [Google Scholar] [CrossRef] [PubMed]
- Arunachalam, G.; Lakshmanan, A.P.; Samuel, S.M.; Triggle, C.R.; Ding, H. Molecular interplay between microRNA-34a and sirtuin1 in hyperglycemia-mediated impaired angiogenesis in endothelial cells: Effects of metformins. J. Pharmacol. Exp. Ther. 2016, 356, 314–323. [Google Scholar] [CrossRef] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Margaritis, K.; Margioula-Siarkou, G.; Giza, S.; Kotanidou, E.P.; Tsinopoulou, V.R.; Christoforidis, A.; Galli-Tsinopoulou, A. Micro-RNA Implications in Type-1 Diabetes Mellitus: A Review of Literature. Int. J. Mol. Sci. 2021, 22, 12165. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms222212165
Margaritis K, Margioula-Siarkou G, Giza S, Kotanidou EP, Tsinopoulou VR, Christoforidis A, Galli-Tsinopoulou A. Micro-RNA Implications in Type-1 Diabetes Mellitus: A Review of Literature. International Journal of Molecular Sciences. 2021; 22(22):12165. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms222212165
Chicago/Turabian StyleMargaritis, Kosmas, Georgia Margioula-Siarkou, Styliani Giza, Eleni P. Kotanidou, Vasiliki Regina Tsinopoulou, Athanasios Christoforidis, and Assimina Galli-Tsinopoulou. 2021. "Micro-RNA Implications in Type-1 Diabetes Mellitus: A Review of Literature" International Journal of Molecular Sciences 22, no. 22: 12165. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms222212165